Search results for “Fenpropidine” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 106 patents, we discovered top 18 key players by total patent application. Syngenta Participations AG, BASF AB, Novartis AG are dominant in this area. They take 72.64% of the total patent filing.
Switzerland
Patent: 43
Sweden
Patent: 21
Basel-Stadt, Switzerland
Patent: 13
Switzerland
Patent: 5
Rohm & Haas Co.
Pennsylvania, United States
Patent: 4
Novartis-Erfindungen Verwaltungsgesellschaft m.b.H.
Austria
Patent: 3
Nordrhein-Westfalen, Germany
Patent: 2
Switzerland
Patent: 2
New Jersey, United States
Patent: 2
Gelderland, Netherlands
Patent: 2
Startups & Unicorns
Order by:
Innovation Intensity
No data, please try another search term
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 15 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Syngenta Participations AG, Syngenta Crop Protection AG, Bayer AG take 80.00% of patent filing during this period.
Switzerland
Patent: 6
undefined undefined
Patent: 4
Nordrhein-Westfalen, Germany
Patent: 2
Gelderland, Netherlands
Patent: 1
ADAMA Makhteshim Ltd.
Israel
Patent: 1
Sweden
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 15 patents in last 5 years, we discover 3 new entrants.
undefined undefined
Patent: 4
Nordrhein-Westfalen, Germany
Patent: 2
ADAMA Makhteshim Ltd.
Israel
Patent: 1
Research Institutions
Order by:
Innovation Intensity
No data, please try another search term
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: